Gustave-Samuel Roussy (1874-1948) : founder of the homonymous Institute of Cancer
Androutsos, G.
Journal of BUON Official Journal of the Balkan Union of Oncology 8(1): 77-81
2003
ISSN/ISBN: 1107-0625 PMID: 17415875 Document Number: 559381
We present briefly through this paper the main stages of life and career of French professor Gustave-Samuel Roussy (1874-1948) as well as his efforts for the foundation of the homonymous Institute of Cancer.
Document emailed within 1 workday
Related Documents
Cachin, Y.; Sauvage, J.P.; Schwaab, G. 1976: Rendu-Osler disease: apropos of 50 cases followed at the Gustave-Roussy Institute Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 93(1-2): 103-108Schwaab, G.; Mamelle, G.; Zbaren, P.; Marandas, P.; Domenge, C.; Eschwege, F. 1988: Cancers of the upper face. The experience of the Gustave Roussy Institute. Apropos of 162 cases (1965-1980) Annales d'oto-laryngologie et de chirurgie cervico faciale: bulletin de la Societe d'oto-laryngologie des hopitaux de Paris 105(3): 173-178
Michel, G.; Pfeiffer, F.; Duvillard, P.; Prade, M.; Castaigne, D.; Zarca, D.; Pejovic-Lenfant, M.H.; Gerbaulet, A.; Lhomme, C. 1989: Sarcoma of the uterus. A clinical study apropos of 50 surgically treated cases at the Gustave Roussy Institute. Review of the literature Journal de Gynecologie Obstetrique et Biologie de la Reproduction 18(8): 1024-1030
Lacour, J. 1970: Therapeutic indications and results of treatment of breast cancer at the Institut Gustave-Roussy L'Union Medicale du Canada 99(11): 2008-2018
Pierquin, B.; Raventos, A.; Chassagne, D. 1970: Endocurietherapy of malignant cervical adenopathy by iridium-192 (124 cases treated at the Institut Gustave-Roussy) Journal de Radiologie d'Electrologie et de Medecine Nucleaire 51(5): 237-240
Rubinstein-Zummer, K.; Beyer, H.P.; Chassagne, D. 1977: Results of the treatment of cutaneous epitheliomas observed at the Institut Gustave-Roussy in 1969 and 1970 Journal de Radiologie d'Electrologie et de Medecine Nucleaire 58(11): 745-747
Sarrazin, D.; Schwaab, G.; Fontaine, F.; Kalifa, C.; Richard, J.; Archambault, R. 1985: Radiotherapy of carcinoma of the nasopharynx in children after previous chemotherapy. Preliminary results on 21 cases treated at the Institut Gustave-Roussy between 1978 and 1981 Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 102(3): 175-178
Vandenbrouck, C.; Marandas, P.; Eschwege, F. 1978: Epitheliomas of the glosso-epiglottic fissure. Therapeutic indications and results. Apropos of 80 cases treated at the Institut Gustave-Roussy from 1968 to 1973 Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 95(1-2): 113-118
Kapeller, K.; Tichý, M.; Frankenberger, Z. 1990: Professor Dr. Zdenĕk Frankenberger, founder and first head of the Histological-Embryological Institute of the Medical Faculty of Komenský University in Bratislava Zeitschrift für Mikroskopisch-Anatomische Forschung 104(2): 177-182
Kovar, H.; Auinger, A.; Jug, G.; Müller, T.; Pillwein, K. 1992: p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree Oncogene 7(11): 2169-2173
Ngo, L.S.M.; Yeo, A.; Wong, A.S.C.; Tay, M.Hiang. 2007: Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore Annals of the Academy of Medicine Singapore 36(10): 811-814
Cierniková, S.; Tomka, M.; Kovác, M.; Stevurková, V.; Zajac, V. 2006: Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families Neoplasma 53(2): 97-102
Chiarodo, A. 1991: National Cancer Institute roundtable on prostate cancer: future research directions Cancer Research 51(9): 2498-2505
Ornellas, A.A.; Khouri, F.R.; Campos, F.; Koifman, N.; Quirino, R. 1999: Cancer of the urethra in women: experience of the National Institute of Cancer of Brazil: 1992-1997 Progres en urologie: journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 9(2): 292-298
Zwiebel, J. 2016: The effect on drug development of the National Cancer Institute's Cancer Therapy Evaluation Program Clinical Advances in Hematology and Oncology: H&o 14(3): 157-159
Talukder, M.H.; Jabeen, S.; Shaheen, S.; Islam, M.J.; Haque, M. 2007: Pattern of cancer in young adults at National Institute of Cancer Research and Hospital (NICRH), Bangladesh Mymensingh medical journal: MMJ 16(2 Suppl): S28-S33
Khoo, U.-S.; Chan, K.Y.K.; Cheung, A.N.Y.; Xue, W.C.; Shen, D.H.; Fung, K.Y.; Ngan, H.Y.S.; Choy, K.W.; Pang, C.P.; Poon, C.S.P.; Poon, A.Y.A.; Ozcelik, H. 2002: Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population Human Mutation 19(3): 307-308
Salvadori, B.; Celio, L.; Oriana, R.; Bajetta, E. 2000: Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: long-term results of an experience at the Milan Cancer Institute Tumori 86(3): 258-259
Shem, S.; Shem, S. 2003: Samuel Shem Lancet 361(9356): 536
Barnett, H.L.; Fraad, L.M.; Gordon, H.H.; Kretchmer, N.; Levine, S.Z. 1972: Samuel Z. Levine Pediatrics 49(5): 780